These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15551510)

  • 1. Exemption of radiopharmaceuticals from <797>.
    Hung JC; VanBrocklin HF
    J Nucl Med; 2004 Oct; 45(10):14N. PubMed ID: 15551510
    [No Abstract]   [Full Text] [Related]  

  • 2. From the SNM Committee on Pharmacopeia: Exemption of radiopharmaceuticals from <797>.
    Hung JC;
    J Nucl Med; 2004 Oct; 45(10):13N, 16N. PubMed ID: 15551509
    [No Abstract]   [Full Text] [Related]  

  • 3. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 4. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

  • 5. JCAHO's compliance expectations for standardized concentrations. Rule of Six in pediatrics does not meet requirements.
    Jt Comm Perspect; 2004 May; 24(5):11. PubMed ID: 15224665
    [No Abstract]   [Full Text] [Related]  

  • 6. Revised ADR report permits internal review of drug experience.
    Jeffrey LP
    Pharm Times; 1986 Dec; 52(12):48-50. PubMed ID: 10317827
    [No Abstract]   [Full Text] [Related]  

  • 7. Working toward uniformity in evaluation of ADR-reporting programs.
    Woodson HA
    Am J Hosp Pharm; 1991 Jul; 48(7):1428. PubMed ID: 1882866
    [No Abstract]   [Full Text] [Related]  

  • 8. Report device failures to the FDA.
    JCAH Perspect; 1987; 7(7-8):5-7. PubMed ID: 10289785
    [No Abstract]   [Full Text] [Related]  

  • 9. Results of advisory panel on USP Chapter 797.
    Jt Comm Perspect; 2004 Oct; 24(10):12-4. PubMed ID: 15560422
    [No Abstract]   [Full Text] [Related]  

  • 10. Probing the safety of central venous catheters.
    Murray EW
    Am J Nurs; 1993 May; 93(5):72, 75-6. PubMed ID: 8488905
    [No Abstract]   [Full Text] [Related]  

  • 11. Look-alike, sound-alike drug names.
    Jt Comm Perspect; 2001 Jul; 21(7):10-1. PubMed ID: 11467264
    [No Abstract]   [Full Text] [Related]  

  • 12. Reporting drug product defects--JCAHO.
    Hoffmann RP
    Hosp Pharm; 1989 Feb; 24(2):143-4. PubMed ID: 10318199
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse drug reaction reporting--proposal to implement a revised system.
    Linkewich JA
    Hosp Pharm; 1989 Feb; 24(2):122-4. PubMed ID: 10292192
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of various requirements of the quality assurance procedures for (18)F-FDG injection.
    Hung JC
    J Nucl Med; 2002 Nov; 43(11):1495-506. PubMed ID: 12411554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. USP and PET radiopharmaceuticals: 1997 FDAMA puts standard-setting body at center of regulatory process.
    Hung JC; Callahan RJ
    J Nucl Med; 2004 Jan; 45(1):13N-14N, 16N. PubMed ID: 14734661
    [No Abstract]   [Full Text] [Related]  

  • 16. Implementation of new requirement under National Patient Safety Goal 3.
    Jt Comm Perspect; 2004 Oct; 24(10):3-9. PubMed ID: 15560419
    [No Abstract]   [Full Text] [Related]  

  • 17. Explanations and unresolved issues pertaining to the development of the Nuclear Pharmacy Compounding Guidelines.
    Hung JC; Augustine SC; Cheng KT; Green RL; Hopkins WM; Laven DL; Nelson BR; Petry NA; Ponto JA; Quinton TM; Swanson DP
    J Am Pharm Assoc (Wash); 2002; 42(5):789-98. PubMed ID: 12269713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Damaged or recalled products.
    Hosp Food Nutr Focus; 1988 Sep; 5(1):1, 3. PubMed ID: 10289840
    [No Abstract]   [Full Text] [Related]  

  • 19. Modifications to compliance data tables for 2003 National Patient Safety Goals.
    Jt Comm Perspect; 2004 Oct; 24(10):14-5. PubMed ID: 15560423
    [No Abstract]   [Full Text] [Related]  

  • 20. Retesting and laboratory investigations.
    Davis JS
    J Pharm Sci Technol; 1994; 48(3):107-9. PubMed ID: 8069512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.